The NWHN applauds the court’s decision, but encourages the public to stay vigilant.
The following statement can be attributed to Cynthia A. Pearson, Executive Director of the National Women’s Health Network. Contact: Evita Almassi, email@example.com or 425-749-1886 The FDA announced that it is reviewing its restrictions on mifepristone, a medication used for miscarriage and abortion care. The announcement came in the evening of May 7, as part of…
Safe and effective FDA-approved abortion pills (aka medication abortion) are now available by mail in several states — without an in-person clinic visit.
We’re calling on the FDA to let pregnant people receive the abortion pill through the mail so that they can get the pill where they take the pill — at home!